Atopic dermatitis - All you can do from the outside

British Journal of Dermatology

Volumn 170, Issue SUPPL. 1, 2014, Pages 19-24

  Gelmetti, C ^a   Wollenberg, A ^b  

^a FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

^b UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CALCINEURIN INHIBITOR; CORTICOSTEROID; EMOLLIENT AGENT; ANTIINFLAMMATORY AGENT; DERMATOLOGICAL AGENT;

ATOPIC DERMATITIS; AVOIDANCE BEHAVIOR; EVIDENCE BASED PRACTICE; HUMAN; HYGIENE; PRIORITY JOURNAL; REVIEW; SELF CARE; TOPICAL TREATMENT; CLINICAL TRIAL (TOPIC); DERMATITIS, ATOPIC; ECONOMICS; INTRADERMAL DRUG ADMINISTRATION; PROCEDURES; SKIN CARE;

ADMINISTRATION, CUTANEOUS; ANTI-INFLAMMATORY AGENTS; CLINICAL TRIALS AS TOPIC; DERMATITIS, ATOPIC; DERMATOLOGIC AGENTS; EMOLLIENTS; HUMANS; HYGIENE; SKIN CARE;

EID: 84902837193     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/bjd.12957     Document Type: Review

References (40)

1. Danby S, Cork MJ,. A new understanding of atopic dermatitis: the role of epidermal barrier dysfunction and subclinical inflammation. J Clin Dermatol 2010; 1: 33-46.
2. Saijic D, Asiniwasis R, Skotnicki-Grant S,. A look at epidermal barrier function in atopic dermatitis: physiologic lipid replacement and the role of ceramide. Skin Therapy Lett 2012; 7: 6-9.
3. Hon KL, Leung AK, Barankin B,. Barrier repair therapy in atopic dermatitis: an overview. Am J Clin Dermatol 2013; 14: 389-99.
4. Hon KL, Pong NH, Wang SS, et al,. Acceptability and efficacy of an emollient containing ceramide-precursor lipids and moisturizing factors for atopic dermatitis in pediatric patients. Drugs R D 2013; 13: 37-42.
5. Gelmetti C, Boralevi F, Seité S, et al,. Quality of life of parents living with a child suffering from atopic dermatitis before and after a 3-month treatment with an emollient. Pediatr Dermatol 2012; 29: 714-18.
6. Miller DW, Koch SB, Yentzer BA, et al,. An over-the-counter moisturizer is as clinically effective as, and more cost-effective than, prescription barrier creams in the treatment of children with mild-to-moderate atopic dermatitis: a randomized, controlled trial. J Drugs Dermatol 2011; 10: 531-7.
7. Williams HC, Chalmers JR, Simpson EL,. Prevention of atopic dermatitis. F1000 Med Rep 2012; 4: 24.
8. Devillers AC, Oranje AP,. Efficacy and safety of 'wet-wrap' dressings as an intervention treatment in children with severe and/or refractory atopic dermatitis: a critical review of the literature. Br J Dermatol 2006; 154: 579-85.
9. Ring J, Darsow U,. Dermatitis. In: Braun-Falco's Dermatology (, Plewig G, Wolff HH, Burgdorf WH, Landthaler M, eds), 3rd edn. Berlin: Springer, 2008.
10. Darsow U, Lübbe J, Taieb A, et al,. Position paper on diagnosis and treatment of atopic dermatitis. J Eur Acad Dermatol Venereol 2005; 19: 286-95.
11. Wollenberg A, Ehmann LM,. Long term treatment concepts and proactive therapy for atopic eczema. Ann Dermatol 2012; 24: 253-60.
12. Darsow U, Wollenberg A, Simon D, et al,. ETFAD/EADV Eczema Task Force 2009 position paper on diagnosis and treatment of atopic dermatitis. J Eur Acad Dermatol Venereol 2010; 24: 317-28.
13. Reitamo S, Rustin M, Ruzicka T, et al,. Efficacy and safety of tacrolimus ointment compared with that of hydrocortisone butyrate ointment in adult patients with atopic dermatitis. J Allergy Clin Immunol 2002; 109: 547-55.
14. Reitamo S, Wollenberg A, Schopf E, et al,. Safety and efficacy of 1 year of tacrolimus ointment monotherapy in adults with atopic dermatitis. The European Tacrolimus Ointment Study Group. Arch Dermatol 2000; 136: 999-1006.
15. Proksch E, Fölster-Holst R, Jensen JM,. Skin barrier function, epidermal proliferation and differentiation in eczema. J Dermatol Sci 2006; 43: 159-69.
16. Werner Y, Lindberg M,. Transepidermal water loss in dry and clinically normal skin in patients with atopic dermatitis. Acta Derm Venereol 1985; 65: 102-5.
17. Wollenberg A, Frank R, Kroth J, et al,. Proactive therapy of atopic eczema-an evidence-based concept with a behavioral background. J Dtsch Dermatol Ges 2009; 7: 117-21.
18. Weidinger S, O'Sullivan M, Illig T, et al,. Filaggrin mutations, atopic eczema, hay fever, and asthma in children. J Allergy Clin Immunol 2008; 121: 1203-9.
19. Macheleidt O, Kaiser HW, Sandhoff K,. Deficiency of epidermal protein-bound omega-hydroxyceramides in atopic dermatitis. J Invest Dermatol 2002; 119: 166-73.
20. Mihm MC Jr, Soter NA, Dvorak HF, Austen KF,. The structure of normal skin and the morphology of atopic eczema. J Invest Dermatol 1976; 67: 305-12.
21. Wollenberg A, Räwer HC, Schauber J,. Innate immunity in atopic dermatitis. Clin Rev Allergy Immunol 2011; 41: 272-81.
22. Wollenberg A, Wen S, Bieber T,. Phenotyping of epidermal dendritic cells: clinical applications of a flow cytometric micromethod. Cytometry 1999; 37: 147-55.
23. Wollenberg A, Bieber T,. Proactive therapy of atopic dermatitis-an emerging concept. Allergy 2009; 64: 276-8.
24. Van Der Meer JB, Glazenburg EJ, Mulder PG, et al,. The management of moderate to severe atopic dermatitis in adults with topical fluticasone propionate. The Netherlands Adult Atopic Dermatitis Study Group. Br J Dermatol 1999; 140: 1114-21.
25. Wollenberg A,. Proaktive und reaktive Behandlungsansätze der Neurodermitis mit differenten Externa. J Dtsch Dermatol Ges 2007; 5 (Suppl. 2): S105.
26. Frankl VE,. Der Mensch auf der Suche nach Sinn. Stuttgart: Ernst Klett Verlag, 1972.
27. Ring J, Alomar A, Bieber T, et al,. Guidelines for treatment of atopic eczema (atopic dermatitis) part I. J Eur Acad Dermatol Venereol 2012; 26: 1045-60.
28. Ring J, Alomar A, Bieber T, et al,. Guidelines for treatment of atopic eczema (atopic dermatitis) part II. J Eur Acad Dermatol Venereol 2012; 26: 1176-93.
29. Hanifin J, Gupta AK, Rajagopalan R,. Intermittent dosing of fluticasone propionate cream for reducing the risk of relapse in atopic dermatitis patients. Br J Dermatol 2002; 147: 528-37.
30. Berth-Jones J, Damstra RJ, Golsch S, et al,. Twice weekly fluticasone propionate added to emollient maintenance treatment to reduce risk of relapse in atopic dermatitis: randomised, double blind, parallel group study. BMJ 2003; 326: 1367.
31. Glazenburg EJ, Wolkerstorfer A, Gerretsen AL, et al,. Efficacy and safety of fluticasone propionate 0.005% ointment in the long-term maintenance treatment of children with atopic dermatitis: differences between boys and girls? Pediatr Allergy Immunol 2009; 20: 59-66.
32. Wollenberg A, Reitamo S, Girolomoni G, et al,. Proactive treatment of atopic dermatitis in adults with 0.1% tacrolimus ointment. Allergy 2008; 63: 742-50.
33. Thaci D, Reitamo S, Gonzalez Ensenat MA, et al,. Proactive disease management with 0.03% tacrolimus ointment for children with atopic dermatitis: results of a randomized, multicentre, comparative study. Br J Dermatol 2008; 159: 1348-56.
34. Reitamo S, Allsopp R,. Treatment with twice-weekly tacrolimus ointment in patients with moderate to severe atopic dermatitis: results from two randomized, multicentre, comparative studies. J Dermatolog Treat 2010; 21: 34-44.
35. Paller AS, Eichenfield LF, Kirsner RS, et al,. Three times weekly tacrolimus ointment reduces relapse in stabilized atopic dermatitis: a new paradigm for use. Pediatrics 2008; 122: e1210-18.
36. Breneman D, Fleischer AB Jr, Abramovits W, et al,. Intermittent therapy for flare prevention and long-term disease control in stabilized atopic dermatitis: a randomized comparison of 3-times-weekly applications of tacrolimus ointment versus vehicle. J Am Acad Dermatol 2008; 58: 990-9.
37. Peserico A, Stadtler G, Sebastian M, et al,. Reduction of relapses of atopic dermatitis with methylprednisolone aceponate cream twice weekly in addition to maintenance treatment with emollient: a multicentre, randomized, double-blind, controlled study. Br J Dermatol 2008; 158: 801-7.
38. Wollenberg A, Sidhu MK, Odeyemi I, et al,. Economic evaluation of maintenance treatment with tacrolimus 0.1% ointment in adults with moderate to severe atopic dermatitis. Br J Dermatol 2008; 159: 1322-30.
39. Ricci G, Neri I, Ricci L, et al,. Silk fabrics in the management of atopic dermatitis. Skin Therapy Lett 2012; 3: 5-7.
40. Wiegand C, Hipler UC, Boldt S, et al,. Skin-protective effects of a zinc oxide-functionalized textile and its relevance for atopic dermatitis. Clin Cosmet Investig Dermatol 2013; 6: 115-21.